encyclopedia jump navigation jump search ovarian_cancer tumour micrograph carcinoma 
oncology symptom pain loss appetite onset age diagnosis year type carcinoma germ cell tumor sex cord tumor risk factor children hormone therapy menopause fertility medication obesity genetics method tissue biopsy treatment surgery radiation therapy chemotherapy survival rate frequency death 
ovarian_cancer cancer form ovary cell ability part body process symptom symptom cancer symptom pain swell loss appetite area cancer line abdomen lymph node lung liver 
risk ovarian_cancer increase women lifetime 
children ovulation age menopause age risk factor hormone therapy menopause fertility medication obesity factor decrease risk birth control ligation breast feed case risk women mutation gene chance disease carcinoma type ovarian_cancer case subtype carcinoma serous carcinoma hgsc tumor cell ovary tube type ovarian_cancer germ cell sex cord diagnosis ovarian_cancer biopsy tissue surgery 
screen women risk evidence reduction death rate test surgery risk risk ovary measure stage ovarian_cancer treatment combination surgery radiation therapy chemotherapy outcome extent disease subtype cancer present condition survival rate united states outcome world 
case women women death women cancer cause death cancer age diagnosis death ovarian_cancer north america europe africa asia content 
sign symptom symptom symptom children risk factor genetics factor factor diagnosis examination pathology screen prevention management surgery radiation therapy therapy follow-up care care factor survival rate rate epidemiology united states united kingdom women pregnancy animal research screen research pharmacology radiation trial reference read link 
sign symptom symptom site ovarian_cancer 
sign symptom ovarian_cancer 
case symptom month symptom bowel syndrome stage ovarian_cancer 
symptom subtype potential borderline increase level ultrasound 
symptom tumor distension pain 
mass borderline 
symptom ovarian_cancer bloat pain discomfort back_pain menstruation postmenopausal pain bleed intercourse loss appetite fatigue indigestion heartburn constipation nausea feel symptom urination urination symptom 
mass pain torsion 
symptom mass abdominopelvic organ metastase symptom history symptom ovarian_cancer sister mary joseph nodule syndrome experience bleed menopause case 
symptom pain mass children 
adolescent children symptom pain irritation peritoneum symptom sex produce hormone development sex characteristics 
sex tumor children puberty pain distension 
adolescent sex 
cancer accumulation fluid abdomen 
malignancy time ascite cancer mass lymph node mass effusion risk factor 
ovarian_cancer amount time 
children risk factor ovarian_cancer ovulation pregnancy 
ovulation cell cycle 
people children risk ovarian_cancer 
period ovulation menstruation menopause risk factor obesity hormone replacement therapy risk 
risk ovarian_cancer women cycle cycle breast feed contraceptive pregnancy pregnancy age 
risk ovarian_cancer women ligation tube ovary hysterectomy operation uterus cervix age risk factor 
use fertility medication borderline tumor formation link study fertility drug risk borderline infertility risk ovarian_cancer infertility birth risk 
shed cell pregnancy cause risk factor infertility treatment 
condition ovary syndrome endometriosis ovarian_cancer link hormone replacement therapy hrt increase risk ovarian_cancer 
association study study women study link 
hrt estrogen progesterone risk year risk return cessation therapy hrt increase risk endometrioid serous risk tumor 
dose increase risk risk factor ovarian_cancer pain menstruation 
clear-cel endometrioid subtype stage grade mortality 
menopause obesity person risk ovarian_cancer risk menopause 
risk hrt 
association ovarian_cancer people genetics information breast ovarian_cancer syndrome people breast_cancer pedigree chart family 
family history ovarian_cancer risk factor ovarian_cancer 
people colon cancer lynch syndrome brca-1 abnormality risk 
risk factor ovarian_cancer mutation brca1 dna mismatch repair gene ovarian_cancer case 
allele person risk 
gene line penetrance mutation gene risk breast_cancer lifetime risk ovarian_cancer risk peak person 
risk mutation brca1 lifetime risk ovarian_cancer mutation brca2 brca1 lifetime risk risk risk brca-associate cancer year counterpart people mutation copy gene mutation process carcinogenesis people gene mutation 
united states women relative ovarian_cancer ovarian_cancer family member triple risk women family member 
women relative ovarian_cancer ovarian_cancer general ovarian_cancer case cause mutation serous ovarian_cancer 
family history cancer colon cancer cancer presence syndrome cancer lynch syndrome risk number cancer ovarian_cancer 
lynch syndrome mutation mismatch repair gene mlh6 risk ovarian_cancer individual lynch syndrome percent people descent descent descent risk ovarian_cancer receptor beta gene key pathogenesis response therapy gene ovarian_cancer chek2 ovarian_cancer 
disorder subtype ovarian_cancer 
syndrome disorder people sex cord tumour tubule ollier disease syndrome cell children tumor 
cell carcinoma syndrome factor 
nation exception japan rate ovarian_cancer diet country 
 risk ovarian_cancer people due factor women children rate surgery risk ovarian_cancer 
cohort study correlation dairy consumption ovarian_cancer study correlation 
evidence effect meat meat ovarian_cancer 
evidence talc pesticide herbicide risk ovarian_cancer cancer society note study link chemical environment diet mutation ovarian_cancer 
alcohol consumption ovarian_cancer factor level vitamin blood presence inclusion cyst infection virus cause case cancer risk factor ovarian_cancer carcinogenicity talc irritant tract ovary study use talc risk ovarian_cancer talc risk use talc body ovarian_cancer period mortality ovarian_cancer 
risk exercise 
age risk factor ovarian_cancer mutation cell cause cancer 
smoke tobacco risk ovarian_cancer smoke cessation risk 
diet animal fat ovarian_cancer connection 
diet role ovarian_cancer risk level protein risk ovarian_cancer factor 
suppression ovulation damage epithelium inflammation 
effect children contraceptive breast factor period breastfeed correlate decrease risk ovarian_cancer birth risk ovarian_cancer effect birth 
contraceptive risk ovarian_cancer effect contraceptive year use aspirin paracetamol risk ovarian_cancer nsaids effect 
ligation carcinogen ovary fimbriae vagina uterus tube ligation women mutation mutation risk removal tube ovary risk ovarian_cancer breast_cancer topic research link hysterectomy ovarian_cancer risk 
reason hysterectomy 
diet amount carotene vitamin amount fatspecifically diet vegetable broccoly onionsmay research area caffeine intake consumption cup tea day ovarian_cancer risk smoke tobacco sex mutation ovarian_cancer subtype gene mutation type prevalence amplification point mutation cell deletion point mutation nonsense mutation brca2 mutation amplification amplification serous deletion cell mutation dynlrb1 mutation amplificationoverexpression serous fm csf-1 point mutation adult cell amplification amplification amplification serous amplification point mutation amplification point mutation amplification deletion point mutation serous amplification point mutation pi3k3 amplification cell cell deletion cell deletion point mutation 
tp53 serous 
ri mutation 
ovarian_cancer form error cell growth 
cell cell place 
cancer cell form cell 
buildup cell mass tissue growth tumor 
cancer cell abnormality ovary egg egg follicle burst corpus 
structure cell ovary ovulation time repair ovary cell mutation division 
gene mutation ovarian_cancer brca1 
type ovarian_cancer instability gene oncogene tumor mutation type cancer pten type cancer type gene cancer mutation kra cancer grade potential mutation type cancer precursor lesion type cancer carcinoma cancer mutation mutation removal gene cancer 
serous cancer recombination dna repair notch foxm1 pathway 
mutation carcinoma degree instability 
recombination dna repair germline mutation gene people ovarian_cancer mutation brca1 mutation found population jew 
mucinous carcinoma mutation kra amplification ovarian_cancer mutation 
carcinoma carcinoma tissue 
carcinoma inclusion cyst group cell stroma diagnosis examination ovarian_cancer ct micrograph carcinoma type ovarian_cancer fluid 
diagnosis ovarian_cancer examination examination blood test ca-125 marker ultrasound examination plan surgery diagnosis surgery cavity biopsy tissue sample analysis look cancer cell fluid 
ovarian_cancer stage symptom use diagnosis result advance stage symptom ovarian_cancer bowel syndrome 
patient pregnancy possibility level diagnosis process 
serum neuron-specific lactate dehydrogenase girl adolescent tumor patient germ cell 
examination examination ultrasound diagnosis examination girth ascite fluid cavity examination mass mass find ovarian_cancer solid mass malignancy cause mass cyst endometriosis pregnancy abscess torsion cyst cystadenoma diverticular abscess nerve sheath tumor kidney bladder mesothelioma tuberculosis cyst 
sign ovarian_cancer postmenopausal women 
part examination ovarian_cancer breast examination exam 
palpation lymph node lymphadenopathy metastasis 
indicator presence effusion 
malignancy list possibility number laboratory test 
blood count serum electrolyte test ovarian_cancer test number platelet people blood sodium level signal tumor test inhibin inhibin  cell tumor 
blood test marker molecule diagnosis follow disease method screen ovarian_cancer due sensitivity specificity level people uml ovarian_cancer elevation ca-125 uml people 
level stage ovarian_cancer stage ovarian_cancer patient ca-125 level condition endometriosis pregnancy fibroid menstruation cyst liver disease bowel disease disease he4 candidate ovarian_cancer test 
tumor marker ovarian_cancer protein mesothelin acid fibroblast growth factor 
use blood test panel diagnosis panel transferrin 
people postmenopausal people risk cancer set laboratory test sex 
level testosterone dehydroepiandrosterone symptom level inhibin scst type 
research way tumor marker combination indicator disease radiology symptom accuracy 
challenge approach prevalence ovarian_cancer test sensitivity specificity number result turn issue procedure cancer 
citation approache ovarian_cancer 
ct scan extent tumor cavity resonance image ct scan cake fluid tumor abdomen potential 
chest x-ray metastase chest effusion 
test disease barium enema colon disease 
emission tomography bone scan paracentesis use fact metastase form needle insertion site result case mass ascite physician ovarian_cancer biopsy case bleed possibility breast malignancy malignancy 
ultrasonography image study mass 
characteristics mass malignancy multilocular feature vessel septation characteristics study 
ovarian_cancer procedure abdomen 
procedure laparotomy incision wall keyhole surgery laparoscopy 
procedure tissue analysis 
salpingo-oophorectomy removal ovary tube 
fluid cavity cell 
cancer procedure extent spread form tumor stage risk score 
method risk ovarian_cancer risk malignancy index rmi initial rmi score risk ovarian_cancer 
rmi ultrasound score score level 
method ultrasound score score score rmi rmi method 
feature rmi rmi 
cyst area ascite metastase 
abnormality abnormality abnormality 
abnormality abnormality 
quantity quantity 
method risk ovarian_cancer risk ovarian_cancer algorithm roca level time ultrasound risk algorithm use level level risk ovarian_cancer rmi 
model probability tumor risk model rule risk calculation assessment neoplasia adnexa model risk malignancy mass characteristics risk factor 
qcancer algorithm likelihood ovarian_cancer risk factor pathology ovarian_cancer women area incidence color survival rate 
ovarian_cancer appearance structure histology histopathology 
histology aspect treatment management prognosis 
pathology ovarian_cancer type mass type ovarian_cancer women age percent ovarian_cancer women age percent ovarian_cancer women age 
subdivision histology surface tumor adenocarcinoma borderline adenocarcinoma data collection interval tumor tumor adenocarcinoma sex tumour carcinoma tumor cell tumor  cell carcinoma brenner tumor  
ovarian_cancer type type 
type cancer grade mucinous clear-cel carcinoma 
type cancer grade carcinoma carcinoma specimen carcinoma 
surface tumour carcinoma type ovarian_cancer ovarian_cancer 
tumour tumor mucinous 
tumor brenner tumor cell carcinoma ovary 
ovarian_cancer epithelium layer cell ovary carcinoma 
people carcinoma carcinoma proportion low-grade carcinoma serous carcinoma chemotherapy treatment carcinoma tube adenocarcinoma body 
adenocarcinoma tube epithelium serous adenocarcinoma show atypia 
time carcinoma case ovary time diagnosis 
diameter cm carcinoma 
carcinoma subtype 
year diagnosis 
cell carcinoma cause blood calcium level ovary 
cell ovarian_cancer ovary women look carcinoma lung carcinoma article carcinoma 
carcinoma peritoneum membrane cavity origin ovary 
ovarian_cancer ovary ovary carcinoma 
carcinoma chemotherapy endometriosis cancer 
women ovarian_cancer group women adenocarcinoma cell cell carcinoma sample 
adenocarcinoma cell carcinoma cell cell 
ovarian_cancer endometriosis cavity 
surgery clear-cel adenocarcinoma prognosis platinum chemotherapy 
adenocarcinoma ovarian_cancer 
endometrioid adenocarcinoma prognosis 
endometriosis cancer müllerian tumor 
müllerian ovarian_cancer 
cell prognosis 
adenocarcinoma mucinous adenocarcinoma article adenocarcinoma 
adenocarcinoma ovarian_cancer 
adenocarcinoma metastase appendiceal colon cancer 
mucinous adenocarcinoma prognosis tumor platinum chemotherapy article 
peritoney collection mucous material cavity primary tumor 
metastase cancer 
cancer cell type ovarian_cancer prognosis microscope tumor cell clump sheet 
clump cell tumor brenner tumor article brenner tumor 
malignant brenner 
stroma area epithelium differentiation 
brenner tumor brenner tumor focy cell carcinoma 
cell carcinoma component tract cancer cell carcinoma article cell carcinoma 
cell carcinoma ovarian_cancer 
bladder carcinoma 
prognosis cancer brenner sex tumor article sex tumor 
sex tumor cell tumor thecoma cell tumor arrhenoblastoma account ovarian_cancer 
women year age women age girl 
sex cord-stromal tumor 
cell mesenchyme rise sex-cord tumor 
fibroblast cell 
symptom sex-cord tumor type ovarian_cancer 
sign symptom torsion rupture tumor mass disruption 
children pseudopuberty cell 
cause abnormality menstruation menstruation menstruation postmenopausal bleed 
produce time cancer breast_cancer 
sex-cordstromal present symptom 
cell cause hair growth production testosterone androstenedione syndrome case 
tumor imbalance fibroma cause ascite hydrothorax germ cell sex tumor ovarian_cancer women cell tumor 
cell tumor case histologic subtype adult cell women granulosa puberty age 
follicle population cell cell adult cell tumor 
adult cell tumor onset year average 
tumor level estrogen symptom hyperplasia breast postmenopausal bleed amenorrhea 
mass tumor symptom pain distension symptom pregnancy tumor granulosa cell tumor cell tumor 
women age puberty tumor 
tumor girl puberty women age cell tumor article germ cell 
cell tumor ovary germ cell cell tumor account tumor ovarian_cancer tumor 
women germ layer tumor cell carcinoma women girl ovarian_cancer age group yolk sac sinus ovary 
germ-cel arm chromosome duplicate cancer prognosis subtype chemotherapy 
stage diagnosis ovarian_cancer 
addition cancer marker tumor type beta-hcg sinus 
sex cord torsion hemorrhage children puberty 
lymph node lymph node symptom germ cell tumor pain tumor bleed capsule 
tumor cause bleed ovary pain tumor 
hormone cycle 
cancer routine examination symptom 
germ cell cycle puberty pain symptom woman symptom pregnancy treatment stigma teen pregnancy 
blood test gonadotropin liver function germ cell tumor potential dysgenesis 
germ cell tumor cyst article 
account ovarian_cancer women germ cell tumor metastasize lymph node metastase  case tumor mutation kit gene mutation role tumor 
people karyotype ovary dysgenesis x0 ovary turner syndrome dysgerminoma risk gonadoblastoma ovary case ovary dysgerminoma risk tumor 
people swyer turner syndrome case 
dysgerminoma time 
cell germ cell 
case hcg level 
appearance tan-color lobe 
seminoma germ cell cell 
nucley nucleoly cytoplasm level glycogen 
feature article 
tumor germ cell disease ovary 
choriocarcinoma prognosis pregnancy 
level hcg puberty children menstruation menarche solid article teratoma 
teratoma type germ cell tumor case 
presence tissue germ layer mesoderm endoderm stem cell cyst 
tissue pathology bone cartilage hair mucus sebum tissue outside mass lobe cyst 
amount neuroectoderm sheet tubule amount tissue grade 
teratoma ovary cyst peritoneum 
teratoma implant abdomen disease teratoma syndrome chemotherapy surgery 
teratoma form adhesion torsion 
marker teratoma antigen ca-125 afp teratoma 
stage majority case prognosis patient year stage tumor grade surgery 
stage tumor quarter case prognosis  patient year cyst article cyst 
teratoma dermoid cyst tissue menopause 
tumor tissue nodule tissue type 
malignancy cell carcinoma adenocarcinoma carcinoma tumor tumor melanoma sarcoma tumor ovariy part cyst 
surgery platinum chemotherapy radiation sac sinus tumor article sac tumor 
sac sinus germ cell malignancy prognosis germ cell 
menarche case menarche case 
people yolk sac stage 
metastasis cavity bloodstream lung 
stage yolk sac disease survival rate stage tumor survival rate 
appearance area 
yolk sac presence body yolk sac pattern 
sac presence level alpha-fetoprotein blood marker recurrence carcinoma article carcinoma 
carcinoma tumor type tumor germ cell case gonad 
variety neoplasm yolk sac tumor teratoma 
people age diagnosis alpha-fetoprotein case hcg 
carcinoma disc anaplastic cell sheet space structure article 
form teratoma tumor body structure germ disk yolk sac sac 
cell cell carcinoma 
cell carcinoma prognosis 
cell carcinoma metastase area differentiation tumor tumor 
tumor element class tumor histology 
tumor type tumor carcinoma combination cell type ovarian_cancer germ cell germ cell ovarian_cancer combination yolk sac tumor teratoma 
prognosis treatment component cell type ovarian_cancer 
ovarian_cancer cancer result metastasis cancer body ovarian_cancer metastase rest cancer 
citation cancer breast_cancer colon cancer cancer stomach_cancer cancer ovary krukenberg signet ring cell cell cancer lymphoma ovary potential 
potential borderline tumor feature tumor ovarian_cancer age 
invasion tumor area microinvasion 3mm tumor 
feature mitosis change cell size nucleus size nucley cell stratification projection cell projection 
andor characteristics examination histology majority lmp 
tumor stage stage stage implant tumor 
ovarian_cancer stage system information surgery hysterectomy midline laparotomy removal ovary tube wash assessment lymph node lymph node mucinous biopsy cytopathology ovarian_cancer ovary cancer cancer stage metastase stage stage 
stage system extent tumor absence presence metastasis lymph node absence presence metastasis  stage diagnosis stage diagnose adenocarcinoma deposit mesentery bowel stage ovarian_cancer stage description cancer ovary ia ovary capsule tumor surface wash ib ovary capsule tumor surface wash tumor ovary spill capsule tumor surface ascite wash extension tumor pelvis tumor ovary iia tumor uterus tube tumor pelvis cancer pelvis lymph node ovary metastasis lymph node extrapelvic metastasis metastasis lymph node metastasis mm diameter metastasis mm diameter metastasis peritoneum lymph node status metastasis peritoneum cm diameter lymph node status metastasis liver spleen capsule metastasis peritoneum cm diameter lymph node status metastasis liver spleen capsule metastasis iva effusion cancer cell metastasis organ parenchyma spleen liver metastasis lymph node 
stage ovarian_cancer 
stage ovarian_cancer 
stage ovarian_cancer 
stage ovarian_cancer 
stage system tumor spread lymph node metastasis stage ovarian_cancer stage description tumor evidence ovary capsule surface tumor ascitesperitoneal wash ovary capsule surface tumor ascitesperitoneal wash ovary capsule capsule surface tumor ascitesperitoneal wash ovary pelvis extension implantation expansion uterus tube wash expansion tissue wash expansion tissue ascitesperitoneal wash ovary pelvis peritoneum liver capsule metastasis metastasis cm diameter metastasis cm diameter lymph node metastasis metastasis  metastasis metastasis metastasis present liver capsule liver parenchyma effusion 
stage stage ia t1a ib t1b t1c iia t2a iib t2b grade 
grade cell tissue prognosis 
grade tumor cell tissue 
grade prognosis cell 
ovarian_cancer abdomen cancer cell capsule cavity 
ovarian_cancer metastase surface organ omentum line 
cancer cell system metastasize lymph node ovary blood vessel lymph node ligament ligament ligament 
group paraaortic iliac lymph node 
ovarian_cancer liver lung brain kidney_disease ovarian_cancer form cancer screen 
way test ovarian_cancer women sign symptom 
screen women risk evidence reduction death rate test surgery risk test ovarian_cancer 
ovarian_cancer stage screen measurement level ultrasound palpation women risk 
risk ovarian_cancer factor 
predisposition screen 
risk group detection 
ovarian_cancer prevalence group women age screen women risk result problem treatment 
result detection problem response result intervention women risk harm screen indication benefit 
purpose screen ovarian_cancer stage 
screen ultrasound examination ca-125 level surgery women mutation 
strategy success prevention 
people risk ovarian_cancer removal ovary measure 
completion childbear year 
chance breast_cancer ovarian_cancer people risk 
women gene mutation tube time risk tube cancer 
statistics risk reduction 
people family history ovarian_cancer counselor test mutation use contraceptive absence period cycle ligation risk association ovarian_cancer stimulation infertility treatment 
papillomavirus infection smoke talc risk ovarian_cancer management 
tube cancer treatment gynecologic physician cancer system 
surgery chemotherapy women ovarian_cancer 
treatment plan 
treatment surgery chemotherapy radiotherapy subtype ovarian_cancer treatment tumor ovary 
addition chemotherapy tumor ovary 
patient disease combination reduction combination chemotherapy regimen 
borderline spread outside ovary surgery chemotherapy surgery maintenance chemotherapy benefit surgery 
surgery standard care decade specimen diagnosis 
surgery extent invasion tissue cancer 
extent cancer stage type grade cancer 
surgeon oophorectomy ovary 
tube uterus hysterectomy omentectomy 
stage-ia cancer ovary tube 
people fertility 
risk metastase stage metastase second surgery ovary uterus acid surgery need blood transfusion blood loss surgery 
tumor woman potential tumor surgery stage cancer ovary 
postmenopausal women potential hysterectomy salpingo-oophorectomy option 
tumor children adolescent ovarian_cancer surgeon ovary completion puberty cancer 
ovary ovary people well-differentiate surgery germ cell surgery cancer fertility factor 
cancer removal option tumor procedure surgery 
surgery women metastase peritoneum disease cancer fissure liver diaphragm area ascite 
surgery debulk outcome women evidence disease debulking survival month month surgery metastase cell chemotherapy clump cell 
chemotherapy cancer cell 
surgery protocol chemotherapy surgery chemotherapy debulk study surgery term survival morbidity 
procedure ovarian_cancer 
stage cancer keyhole surgery metastase 
cancer laparoscopy metastase access cavity 
extent cancer procedure salpingo-oophorectomy biopsy peritoneum system bowel resection diaphragm strip resection exenteration 
stage ovarian_cancer lymphadenectomy surgery survival benefit practice germ cell lymph node 
ovarian_cancer surgery treatment option 
tumor fluid abdomen health people surgery generalist ovarian_cancer surgery dysgerminoma teratoma 
side effect oophorectomy women menopause osteoporosis 
surgery hormone replacement therapy women 
therapy combination estrogen progesterone 
hysterectomy uterus estrogen risk cancer therapy surgery survival rate people ovarian_cancer surgery day month home surgery outcome hospital number ovarian_cancer surgery 
laparoscopy laparotomy stage ovarian_cancer difference hysterectomy hysterectomy cancer 
people surgery ovarian_cancer week surgery mortality rate surgery outcome stage ovarian_cancer 
standard care ovarian_cancer decade protocol 
surgery disease 
case reason chemotherapy surgery 
chemotherapy tumor surgery 
increase survival risk complication surgery 
salpingo-oophorectomy surgery chemotherapy chemotherapy chemotherapy stage cancer tumor histologic grade grade substage stage cancer surgery chemotherapy tumor surgery cancer stage survival survival chemotherapy ovarian_cancer germ cell 
ovarian_cancer group drug 
therapy cisplatin doxorubicin 
combination paclitaxel combination carboplatin cisplatin side effect quality life comparison three-drug regimen combination cavity chemotherapy survival survival side effect chemotherapy cancer 
chemotherapy ovarian_cancer cavity dose drug tumor way 
iron iron supplement need blood transfusion cycle treatment treatment week week week cycle treatment week malignancy ovarian_cancer regimen bleomycin cisplatin bep day chemotherapy week cycle germ cell infertility birth_defect miscarriage maintenance chemotherapy 
people mutation platinum chemotherapy germ-cel sex-cordstromal chemotherapy tumor 
ovarian_cancer time recurrence cancer month treatment platinum-resistant cancer interval month 
chemotherapy cancer difference survival ca-125 recurrence 
platin drug choice chemotherapy combination agent 
doxorubicin therapy paclitaxel efficacy case 
therapy recurrence survival survival inhibitor fda use ovarian_cancer chemotherapy germ cell cycle chemotherapy treatment tho surgery platin 
tumor dactinomycin cyclophosphamide combination paclitaxel therapy 
tumor chemotherapy option 
regimen response rate regimen liposomal case people blockage 
regimen doxorubicin cisplatin topotecan cyclophosphamide care 
radiation therapy 
radiation infertility favor chemotherapy radiation therapy survival people tumor 
stage cancer radiation therapy surgery possibility disease pelvis abdomen 
radiotherapy care cancer 
course radiotherapy ovarian_cancer day week week 
side effect radiotherapy constipation urination therapy 
fact tumor receptor ovarian_cancer treatment 
effect cancer tamoxifen women borderline malignancy ovarian_cancer ovarian_cancer therapy 
topic research ovarian_cancer 
case antibody drug topic research cancer chemotherapy use union follow-up 
follow-up example type stage ovarian_cancer treatment presence symptom 
check-up appointment month year year ovarian_cancer test follow-up level 
treatment level symptom side effect prolongation life implication outcome test recommendation  cancer level recurrence ca-125 survival 
women follow-up test afp gonadotropin 
women cancer test hormone testosterone inhibin progress tumor substance 
afp tumor lactate dehydrogenase isozyme test recurrence 
women ovarian_cancer routine surveillance image cancer symptom tumor marker image indication recurrence survival cost side effect ct image tumor image progress treatment care 
care symptom quality life 
type treatment purpose cancer woman cancer 
part treatment plan person ovarian_cancer patient symptom platinum-refractory platinum-resistant case chemotherapy treatment 
care treatment symptom complication cancer pain nausea constipation ascite bowel obstruction effusion mucositis 
cancer advance treatment symptom goal therapy 
care decision-make hospice care place patient end life care 
bowel obstruction surgery colostomy ileostomy bypass medicine surgery increase survival time surgery bowel syndrome fistula re-obstruction extent obstruction treatment complication nutrition diet palliative pain control bowel obstruction octreotide surgery option 
cancer ureter nephrostomy 
paracentesis placement drain comfort effusion manner thoracentesis placement drain 
radiation therapy part care ovarian_cancer symptom radiotherapy treatment course therapy radiotherapy palliation germ cell care 
ovarian_cancer effect quality life health well-be 
need support 
ovarian_cancer survivor quality life optimism 
change mean experience 
loss faith diagnosis ovarian_cancer 
treatment experience isolation benefit relationship survivor 
frustration guilt inability care family 
body image change hair_loss removal ovary structure scar 
improvement hair 
removal ovary result menopause intercourse dryness loss desire 
prognosis survivor impact sexuality 
anxiety depression distress ovarian_cancer rate population problem family member 
effect fear death sadness memory problem difficulty 
optimism begine treatment distress 
fear cancer difficulty joy 
treatment woman loss hope 
women effect number strategy 
activity spend time family friend statistics involvement event survival ovarian_cancer stage 
ovarian_cancer prognosis 
detection screen test mean case stage 
ovarian_cancer development 
tumor cell cavity women ovarian_cancer cancer ovary 
ovarian_cancer shed cell fluid cavity 
cell structure uterus bladder bowel line bowel wall omentum tumor growth cancer 
survival rate stage ovarian_cancer survival rate survival rate case diagnosis disease cancer site survival rate women disease treatment remission half women recurrence year treatment brain metastasis stage cancer cancer 
people brain metastase median month surgery chemotherapy brain radiation therapy survival 
ovarian_cancer survival subtype 
stage survival rate stage survival chemotherapy removal survival rate 
malignancy prognosis disease decade potential prognosis tumor implant cavity 
complication ovarian_cancer spread cancer organ function loss organ ascite obstruction 
obstruction site cause death obstruction ovarian_cancer obstruction tumor lumen pseudo-obstruction tumor peristalsis accumulation ascite drain factor 
number factor ovarian_cancer 
factor chance survival disease surgery stage resection stage brca2 mutation age year type histologic grade stage co-occurrence cancer ca-125 level 
evidence brca1 factor 
factor chance survival rupture capsule surgery age year type stage grade cell type involvement ca-125 level presence tumor cell blood cyclooxygenase-2 
expression mrna ovarian_cancer 
level drosha survival level hif1a polymerase survival 
wt1 prognosis cancer prognosis survival rate 
survival rate type ovarian_cancer stage grade stage survival grade survival grade grade grade 
survival rate type ovarian_cancer cancer society cancer institute patient 
ovarian_cancer stage survival rate ia ib ic iia iib tumor stage survival rate cell tumor ovary stage survival rate tube carcinoma stage survival rate potential stage survival rate rate 
ovarian_cancer treatment 
period stage cancer 
recurrence abdomen recurrence disease month treatment month survival 
interval increase recurrence dysgerminoma year diagnosis germ cell year time 
cell prognosis survival rate potential relapse surgery treatment choice relapse surgery ovary surgery 
tumor year relapse surgery tumor characteristics 
case ascite chemotherapy 
level relapse month sex tumor treatment 
gynecologic cancer epidemiology death ovarian_cancer inhabitant data 
number case country country people ovarian_cancer 
increase  number case year europe women europe lithuania latvia ireland slovakia republic incidence ovarian_cancer portugal cyprus incidence  survival rate 
survival rate state ovarian_cancer case age group 
united states case women ovarian_cancer 
diagnose tumor 
 diagnose ovarian_cancer lifetime risk ovarian_cancer cause death women united states cancer women cause cancer death decrease cancer women 
risk type ovarian_cancer 
cell sex tumor 
number case year women women 
people tumor germ cell total ovarian_cancer ovarian_cancer cancer women united kingdom 
cancer uk women uk incidence rate population 
kingdom diagnose death risk uk 
women brca allele time rest population risk ovarian_cancer cause death  ovarian_cancer cancer women uk women disease cause cancer death women women ethnicity 
women risk sex cord-stromal women women 
incidence rate women rate ovarian_cancer women age cohort age cohort ovarian_cancer menopause age 
percent ovarian_cancer women age women women ovarian_cancer pregnancy 
germ cell type ovarian_cancer pregnancy 
mass examination pregnancy tumor ultrasound parent level alpha-fetoprotein 
cyst dysgerminoma germ cell pregnancy 
cell pregnancy surgery case chemotherapy risk birth_defect 
sac teratoma chemotherapy pregnancy childbirth animal 
tumor type cystadenocarcinoma cell tumor research screen 
screen hysteroscopy cell sample examination 
pap smear cancer uk trial ovarian_cancer screen screen technique blood test ultrasound study screen procedure result evidence screen live result trial result end 
problem screen progression disease stage stage cancer reach stage 
problem screen method lesion cancer malignancy surgery method ultrasonography women screen method 
women promise population study progress screen help cancer people mutation research 
research factor ovarian_cancer 
research survival stage cancer research benefit surgery ovarian_cancer 
area research immunotherapy trial antibody inhibitor growth blood vessel cancer result combination pazopanib process blood vessel growth 
study stage-iiy cancer response rate ovarian_cancer pharmacology 
inhibitor treatment   side effect drug survival benefit 
kinase inhibitor interest cause 
drug inhibitor 
survival mutation 
platinum chemotherapy combination result pf result survival 
disadvantage treatment side effect profile blood pressure proteinuria 
drug bowel disease fistulae bowel perforation 
antifolate trial folate receptor ovarian_cancer immunotherapy positive mutation angiogenesis inhibitor ovarian_cancer treatment 
combination ovarian_cancer 
angiogenesis inhibitor 
antibody farletuzumab adjuvant chemotherapy 
type immunotherapy vaccine 
alternative chemotherapy regimen cycle carboplatin topic research germ cell malignancy 
chemotherapy investigation   potential dose agent 
trial cisplatin survival regimen chemotherapy agent 
chemotherapy regimen cancer investigation cisplatin 
inhibitor promise trial people gene mutation protein pathway 
ovarian_cancer general study 
survival doxorubicin treatment 
responsiveness inhibitor inhibitor brca-positive ovarian_cancer 
inhibitor ovarian_cancer 
kinase inhibitor drug class application ovarian_cancer 
inhibitor receptor tyrosine kinase inhibitor group cediranib increase progression survival benefit survival research platin ovarian_cancer time second recurrence month survival month tyrosine kinase inhibitor combination paclitaxel carboplatin cancer mutation 
therapy combination cyclophosphamide people recurrence 
inhibitor area research 
hormone therapy topic research ovarian_cancer value medication breast_cancer 
study benefit tamoxifen number people ovarian_cancer 
growth receptor ovarian_cancer 
postmenopausal people cancer 
research side effect ovarian_cancer treatment 
radiation fibrosis formation scar tissue area radiation oxygen therapy research area 
treatment ovarian_cancer people difficulty depression 
research psychotherapy people ovarian_cancer treatment 
indication disease ovarian_cancer country 
process present disease trial 
trial organization test treatment option 
nih research trial institute health trial cancer institute search trial cancer institute institute health trial canada 
